Myricetin, >=96.0% (HPLC)

Myricetin, >=96.0% (HPLC)

Application

Myricetin has been used:to study its preventive effect as an antioxidant on noise-induced hearing loss (NIHL) in ratsas a flavonoid compound to test antiviral activity of Bourbon virus (BRBV) and in inhibition of RNA-dependent RNA polymerase (RdRP)to study its effect as a treatment on biofilms of Streptococcus mutans and Candida albicansas a reference standard for the quantification of phenolic compounds from Juniperus species

Biochem/physiol Actions

Myricetin exerts anti-oxidant effects, and anti-inflammatory effects by regulating multiple signal pathways. It also displays anti-diabetic and hepatoprotective effects. Myricetin strongly inhibits yeast ?-glucosidase, glyoxalase I in vitro, and bovine milk xanthine oxidase. It also promotes complex formation between DNA and both topoisomerase I and II, an effect that may have implications in cancer chemotherapy. Myricetin also has various nutraceuticals values and therapeutic effects.

General description

Myricetin (MYR) is a natural polyhydroxyflavonol compound, first isolated from the bark of Morella rubra (Myrica rubra) tree.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level mp InChI key InChI Manufacturer Form Assay Price Quantity
3577575 Myricetin, >=96.0% (HPLC) 200 >300 °C (lit.), ≥300 °C IKMDFBPHZNJCSN-UHFFFAOYSA-N 1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H SIGMA-ALDRICH powder ≥96.0% (HPLC)
£519.32 (exc VAT) per 100MG
-
+
3577576 Myricetin, >=96.0% (HPLC) 200 >300 °C (lit.), ≥300 °C IKMDFBPHZNJCSN-UHFFFAOYSA-N 1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H SIGMA-ALDRICH powder ≥96.0% (HPLC)
£149.32 (exc VAT) per 25MG
-
+